TELIX PHARMACEUTICAL ORDINARY (TLX) Short Interest
TELIX PHARMACEUTICAL ORDINARY (ASX:TLX) had 15.15% of shares reported as short positions as of 4 June 2026, representing 51,413,200 shares. TELIX PHARMACEUTICAL ORDINARY operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
- Short interest
- 15.15%
- Reported positions
- 51,413,200
- Industry
- Pharmaceuticals, Biotechnology & Life Sciences
- As of
- 4 June 2026
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
TLX
Telix Pharmaceuticals
Telix Pharmaceuticals is a global biopharmaceutical company specializing in the development and commercialization of radiopharmaceuticals for cancer treatment. The company focuses on precision oncology, utilizing targeted radiation to treat urologic, neurologic, and musculoskeletal cancers. Telix's unique value lies in its ability to deliver focused radiation doses with precision targeting, minimi...